EUTM file information

018639876

MediLinkThera


January 18, 2022

Trademark Summary

The trademark application MediLinkThera was filed by MediLink Therapeutics(Suzhou)Co.,Ltd., a corporation established under the laws of the People's Republic of China (the "Applicant"). The application was published for oppositions on March 3, 2022, and it was registered by office on June 10, 2022 without any oppositions.

The application was filed in English (Spanish was selected as the second language).


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Biological preparations for the treatment of cancer
    2. Biological preparations for veterinary purposes
    3. Biological preparations for medical purposes
    4. Biotechnological preparations for medical use
    5. Chemicals for pharmaceutical use
    6. Chemical preparations for sanitary purposes
    7. Chemical preparations for medical purposes
    8. Chemical preparations for veterinary purposes
    9. Chemical preparations for pharmaceutical purposes
    10. Anti-neoplastic preparations of chemical origin
    11. Pharmaceuticals
    12. Pharmaceutical compositions
    13. Pharmaceutical drugs
    14. Pharmaceutical preparations
    15. Chemico-pharmaceutical preparations
    16. Pharmaceutical preparations for veterinary use
    17. Pharmaceutical preparations for suppressing tumors
    18. Pharmaceutical preparations for medical purposes
    19. Pharmaceutical preparations for immunity adjustment
    20. Pharmaceutical preparations for human use
    21. Synthetic peptides for pharmaceutical purposes
    22. Alkaloids used for pharmaceutical purposes
    23. Pharmaceutical preparations for use in hematology
    24. Pharmaceutical preparations for use in oncology
    25. Pharmaceutical preparations for activating cellular function
    26. Pharmaceutical preparations for treating malignant tumors
    27. Pharmaceutical preparations for use in chemotherapy
    28. Pharmaceutical preparations for the treatment of tumours
    29. Pharmaceutical preparations for the treatment of cancer
    30. Pharmaceutical products for the treatment of cancer
    31. Pharmaceutical preparations for the prevention of tumours
    32. Pharmaceutical preparations and substances for use in oncology
    33. Pharmaceutical preparations and substances for the prevention of cancer
    34. Pharmaceutical preparations and substances for the treatment of cancer
    35. Drug delivery agents that facilitate the delivery of pharmaceutical preparations
    36. Cardiovascular preparations
    37. Anticancer preparations
    38. Antiviral preparations
    39. Medical preparations
    40. Medicine
    41. Medicines for human purposes
    42. Medicines for veterinary purposes
    43. Medicines for the treatment of cardiovascular and cerebrovascular diseases
    44. Antineoplastic drugs
    45. Crude drugs
    46. Antitumor drugs
    47. Cytostatic drugs for medical purposes
    48. Anti-cancer drugs
    49. Tumor suppressing agents
    50. Anti-cancer preparations
    51. Compounds for treating cancer
    52. Biopharmaceuticals for the treatment of cancer
    53. Anti-cancer preparations of chemical origin
    54. Antibodies
    55. Medicinal preparations for the treatment of infectious diseases
    56. Diagnostic preparations for medical purposes
    57. Living cells for medical use
    58. Pharmaceutical preparations for peripheral nervous system
    59. Pharmaceutical preparations for the central nervous system
    60. Pharmaceutical preparations for treating peripheral nervous system disorders
    61. Pharmaceutical preparations for the prevention of diseases of the nervous system
    62. Pharmaceutical preparations for the prevention of disorders of the nervous system
    63. Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases
    64. Pharmaceutical preparations for the treatment of autoimmune disorders
    65. Pharmaceutical preparations for the prevention of autoimmune diseases
    66. Pharmaceutical preparations for the prevention of autoimmune disorders
    67. Pharmaceutical preparations for the treatment of autoimmune diseases
    68. Vaccines.
  • The mark was filed in class 35 with following description of goods:
    1. Retail services in relation to veterinary preparations
    2. Wholesale services in relation to veterinary preparations
    3. Retail or wholesale services for pharmaceutical, veterinary and sanitary preparations and medical supplies
    4. Retail services for pharmaceutical, veterinary and sanitary preparations and medical supplies
    5. Retail services in relation to pharmaceutical preparations
    6. Wholesale services in relation to pharmaceutical preparations
    7. Wholesale services for pharmaceutical, veterinary and sanitary preparations and medical supplies
    8. Retail services in relation to medical apparatus
    9. Wholesale services in relation to medical apparatus
    10. Retail services in relation to veterinary articles
    11. Wholesale services in relation to veterinary articles
    12. Advertising relating to pharmaceutical products and in-vivo imaging products.
  • The mark was filed in class 42 with following description of goods:
    1. Laboratory services relating to the production of monoclonal antibodies
    2. Research and development services in the field of antibodies
    3. Biological development services
    4. Biological research services
    5. Biological research and analysis
    6. Biological research laboratory services
    7. Biological research, clinical research and medical research
    8. Preparation of biological samples for research purposes
    9. Biotechnology testing
    10. Biotechnology research
    11. Research relating to biotechnology
    12. Biotechnological research relating to industry
    13. Consultancy in the field of biotechnology
    14. Biotechnological research relating to enzymatic synthesis
    15. Research and development in the field of biotechnology
    16. Research and development in the pharmaceutical and biotechnology fields
    17. Providing information relating to scientific research in the fields of biochemistry and biotechnology
    18. Information on the subject of scientific research in the field of biochemistry and biotechnology
    19. Chemical analysis
    20. Chemical research
    21. Chemical research services
    22. Chemical technological research
    23. Chemical research and analysis
    24. Chemical research and analysis services
    25. Pharmaceutical research services
    26. Pharmaceutical products development
    27. Research of pharmaceuticals
    28. Pharmaceutical research and development
    29. Pharmaceutical drug development services
    30. Research relating to pharmaceuticals
    31. Pharmaceutical research and development services
    32. Development of pharmaceutical preparations and medicines
    33. Conducting clinical trials for pharmaceutical products
    34. Laboratory research services relating to pharmaceuticals
    35. Research on the subject of pharmaceuticals
    36. Research and development for the pharmaceutical industry
    37. Consultancy in the field of pharmaceutical research
    38. Consultancy relating to pharmaceutical research and development
    39. Services for assessing the efficiency of pharmaceuticals
    40. Information technology services for the pharmaceutical and healthcare industries
    41. Conducting early evaluations in the field of new pharmaceuticals
    42. Providing information about the results of clinical trials for pharmaceutical products
    43. Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
    44. Research and development in the field of diagnostic preparations
    45. Scientific research for medical purposes in the area of cancerous diseases
    46. Research and development services in the field of antibody technology.
Trademarkers